← All diseases Liver, kidneys and digestion

Liver cirrhosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest Quality Evidence Only (112)Meta-analysis (33)Treatment guideline (8)Randomized trial (33)Systematic review (22)Phase 3 study (16)Clinical trial (636)Review article (465)Early study (phase 1 or 2) (8)Laboratory or animal research (168)Case report (153)Commentary or editorial (44)Retracted Publication (4) Studies Currently Seeking Participants Only (38)

Filter

Publications and studies (3132)

• A study of the clinical profile, predictors, prognostic features, and survival of patients with hepatocellular carcinoma having macroscopic portal vein tumor thrombosis. (2022/12/01) ♡
• Optimal Tuning of Random Survival Forest Hyperparameter with an Application to Liver Disease. (2022/12/01) ♡
• Prevalence of non-alcoholic fatty liver disease among diabetes, prediabetes and healthy population. (2022/12/01) ♡
• Sociodemographic and medical characteristics of liver cirrhosis deaths in a Ghanaian tertiary hospital. (2022/12/01) ♡
• Identified in blood diet-related methylation changes, stratify liver biopsies or NAFLD patients according to fibrosis grade. (2022/11/30) ♡
• A simple covert hepatic encephalopathy screening model based on blood biochemical parameters in patients with cirrhosis. (2022/11/30) ♡
• The long-term quality of life following liver transplantation in a developing country with a free health care system. (2022/11/30) ♡
• Inhibition of 11β-hydroxysteroid dehydrogenase 1 relieves fibrosis through depolarizing hepatic stellate cell in NASH. (2022/11/29) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Machine learning insights concerning inflammatory and liver-related risk comorbidities in non-communicable and viral diseases. (2022/11/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Features of Lipid Metabolism Disorders in Primary Biliary Cholangitis. (2022/11/25) ♡
• Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease. (2022/11/22) ♡
• Dysglycemia in young women attenuates the protective effect against fatty liver disease. (2022/11/21) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cirrhosis With Splenomegaly and Pancytopenia Complicating a Concurrent Diagnosis of Acute Lymphoblastic Leukemia. (2022/11/20) ♡
• [The study of a key molecule Caspase-1 of inflammasome in hepatitis B virus-related diseases]. (2022/11/20) ♡
• [Analysis of risk factors for decompensated cirrhosis complicated with sepsis]. (2022/11/20) ♡
• [Rifaximin improves clinical symptoms and short-term survival in cirrhotic patients with refractory type ascites]. (2022/11/20) ♡
• [Overexpression of Numb gene can inhibit the progression of biliary liver fibrosis in adult liver]. (2022/11/20) ♡
• [Characteristic analysis of patients with type 2 diabetes mellitus combined with advanced stage chronic liver disease: a community population-based cross-sectional study in Heping District, Shenyang City (CHESS-LN 2101)]. (2022/11/20) ♡
• [Clinical significance of ultrasound combined with serological indexes for predicting nonalcoholic fatty liver disease in patients with chronic hepatitis B with normal or slightly elevated alanine aminotransferase]. (2022/11/20) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. [Meta-analysis of β-blockers for the primary prevention of liver cirrhosis with clinically significant portal hypertension with no or small esophageal varices]. (2022/11/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [New recognition of portal vein thrombosis mechanism and treatment in cirrhosis]. (2022/11/20) ♡
• [Characteristics and research progress on the role of intestinal fungi in chronic liver disease]. (2022/11/20) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy and safety of Fufang Biejia Ruangan Tablets as an adjuvant treatment for chronic hepatitis B liver fibrosis: A systematic review and meta-analysis. (2022/11/18) ♡
• Creatine consumption and liver disease manifestations in individuals aged 12 years and over. (2022/11/18) ♡
• Risk Association of Liver Cancer and Hepatitis B with Tree Ensemble and Lifestyle Features. (2022/11/17) ♡
• Impact of cardiac and noncardiac cirrhosis on coronary revascularization outcomes from the National Inpatient Sample, 2016 to 2018. (2022/11/17) ♡
• Obliterative portal venopathy: A neglected and probably misdiagnosed disease with peculiar etiology in South America. (2022/11/16) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. O-GlycNacylation Remission Retards the Progression of Non-Alcoholic Fatty Liver Disease. (2022/11/16) ♡
• Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trial. (2022/11/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of FGF21 and its analogs on liver associated diseases. (2022/11/15) ♡
• Circulating Adipokines and Hepatokines Serve as Diagnostic Markers during Obesity Therapy. (2022/11/14) ♡
• Cirrhosis and hernia repair in a cohort of 6352 patients in a tertiary hospital: Risk assessment and survival analysis. (2022/11/11) ♡
• Protective Effect of Hydroalcoholic Extract of Clove on Thioacetamide-Induced Hepatotoxicity Animal Model: Effects Hydroalcoholic Extract of Clove Against Hepatotoxicity. (2022/11/11) ♡
• Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II). (2022/11/10) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recreational Drugs and the Risk of Hepatocellular Carcinoma. (2022/11/02) ♡
• Liver steatosis and fibrosis in people with human immunodeficiency virus in West Africa and the relationship with hepatitis B virus coinfection. (2022/11/01) ♡
• Si-Wu-Tang ameliorates bile duct ligation-induced liver fibrosis via modulating immune environment. (2022/11/01) ♡
• [Chemical constituents and anti-liver fibrosis mechanism of Meconopsis quintuplinervia based on UPLC-Q-Exactive-MS/MS and network pharmacology]. (2022/11/01) ♡
• Association between History of Pregnancy and Liver Fibrosis Using Fibrosis-4 Index in Korean Postmenopausal Women: A Nationwide Population-Based Study. (2022/11/01) ♡
• Validation of Spleen Shear Wave Elastography for the Screening of High-risk Varices in Patients with Compensated Advanced Chronic Liver Disease. (2022/11/01) ♡
• [Cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in cirrhotic patients]. (2022/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Single-pass albumin dialysis as treatment of acute on chronic liver failure during COVID-19 pneumonia. report of one case]. (2022/11/01) ♡
• Serum NT-ProBNP potential marker of cirrhotic cardiomyopathy. (2022/10/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Metastatic Hepatocellular Carcinoma Masquerading as an Expansile Osteolytic Lesion in Scapula: A Rare Case of Isolated Appendicular Skeletal Metastatic Involvement of Hepatocellular Carcinoma at Initial Presentation. (2022/10/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Promising traditional Chinese medicine for the treatment of cholestatic liver disease process (cholestasis, hepatitis, liver fibrosis, liver cirrhosis). (2022/10/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An optimized herbal combination for the treatment of liver fibrosis: Hub genes, bioactive ingredients, and molecular mechanisms. (2022/10/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ayurvedic treatment induced severe alcoholic hepatitis and non-cirrhotic portal hypertension in a 14-year-old girl. (2022/10/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Potential Therapeutic Implication of Herbal Medicine in Mitochondria-Mediated Oxidative Stress-Related Liver Diseases. (2022/10/17) ♡
• Study on the mechanism of anti-hepatic fibrosis of Glycyrrhiza Uralensis-Salvia miltiorrhiza prescription based on serum and urine metabolomics and network pharmacology. (2022/10/15) ♡
• Network Pharmacology-Based Exploration on the Intervention of Qinghao Biejia Decoction on the Inflammation-Carcinoma Transformation Process of Chronic Liver Disease via MAPK and PI3k/Akt Pathway. (2022/10/14) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.